Syon Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Syon Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Sell	14,032 -3,064	-18%	-$383K	0.09%	164
2025 Q4	$2.08M	Sell	17,096 -1,512	-8%	-$173K	0.1%	147
2025 Q3	$1.86M	Buy	18,608 +1,604	+9%	+$144K	0.1%	140
2025 Q2	$1.41M	Sell	17,004 -219	-1%	-$17.5K	0.09%	152
2025 Q1	$1.4M	Sell	17,223 -13,622	-44%	-$1.22M	0.11%	135
2024 Q4	$2.78M	Buy	+30,845	New	+$2.99M	0.25%	67

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Syon Capital's XBI Position: Q1 2026 in Review

Syon Capital reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 18% in Q1 2026, selling an estimated $383K and leaving 14,032 shares worth $1.79M. The position accounts for 0.09% of the portfolio, ranked #164.

Syon Capital first reported a position in XBI in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.78M in Q4 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Syon Capital held 14,032 shares of State Street SPDR S&P Biotech ETF worth $1.79M as of Q1 2026.
Syon Capital sold 3,064 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $383K.
State Street SPDR S&P Biotech ETF made up 0.09% of Syon Capital's portfolio in Q1 2026, its #164 holding.
Syon Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 6 quarters since.
Syon Capital's State Street SPDR S&P Biotech ETF position peaked at $2.78M in Q4 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.